Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Non-endometrioid and high-grade endometrioid endometrial cancers show DNA fragmentation factor 40 (DFF40) and B-cell lymphoma 2 protein (BCL2) underexpression, which predicts disease-free and overall survival, but not DNA fragmentation factor 45 (DFF45) underexpression

Fig. 2

Kaplan-Meier survival curves for overall and disease-free survival in DFF40*-, DFF45**-, and BCL2***-negative and positive cases in the entire study cohort and in Groups A$ and B$$, respectively. *DFF40 - DNA fragmentation factor 40; **DFF45 - DNA fragmentation factor 45; ***BCL2 - B-cell lymphoma 2; $Group A – includes low- and moderate-grade endometroid endometrial cancers; $$Group B – includes non-endometroid and high-grade endometroid endometrial cancers; #p-value statistically significant

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us